ProUroCare Medical Inc.
PUMD · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -65,158.81% | -51,934.89% | -160,274.48% | -329,129.64% |
| EV / EBITDA | -0.45 | -0.81 | -0.47 | -0.40 |
| Quality | ||||
| ROIC | 78.69% | 134.76% | 0.00% | 0.00% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.38 | 0.41 | 0.36 | 0.45 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -34.93% | 61.45% | 31.03% | -187.81% |
| Safety | ||||
| Net Debt / EBITDA | -0.45 | -0.81 | -0.46 | -0.40 |
| Interest Coverage | -8.00 | -12.85 | -1.54 | -3.24 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |